Intelligent Investor

Australian Pharmaceutical Industries Limited (ASX: API) - Announcements

DELISTED - Current share price for API : $1.530

ASX company news and announcements for Australian Pharmaceutical Industries Limited (API) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Pharmaceutical Industries Limited (API) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Pharmaceutical Industries Limited (API), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Pharmaceutical Industries Limited (API)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Removal from Official List 1 Apr 2022 9:02AM $1.530 $1.530 $1.530 fallen by 0%
- WES: Completion of API acquisition 31 Mar 2022 3:03PM $1.530 $1.530 $1.530 fallen by 0%
- Implementation of Scheme of Arrangement 31 Mar 2022 2:31PM $1.530 $1.530 $1.530 fallen by 0%
- Notification of cessation of securities - API 29 Mar 2022 3:35PM $1.530 $1.530 $1.530 fallen by 0%
- Change of Director's Interest Notice 29 Mar 2022 3:24PM $1.530 $1.530 $1.530 fallen by 0%
- Notification of cessation of securities - API 29 Mar 2022 3:16PM $1.530 $1.530 $1.530 fallen by 0%
- Letter to Shareholders - Special Dividend Payment 29 Mar 2022 9:29AM $1.530 $1.530 $1.530 fallen by 0%
- Ceasing to be a substantial holder from MUFG 25 Mar 2022 6:46PM $1.530 $1.530 $1.530 fallen by 0%
- Ceasing to be a substantial holder 24 Mar 2022 8:04PM $1.530 $1.530 $1.530 fallen by 0%
- Suspension from Official Quotation 22 Mar 2022 7:00PM $1.530 $1.530 $1.530 fallen by 0%
- Update - Dividend/Distribution - API 22 Mar 2022 10:52AM $1.530 $1.530 $1.530 fallen by 0%
- Scheme now Legally Effective 22 Mar 2022 10:44AM $1.530 $1.530 $1.530 fallen by 0%
- WES: Federal Court approves API Scheme of Arrangement 21 Mar 2022 11:50AM $1.530 $1.530 $1.530 fallen by 0%
- Scheme approved by Court 21 Mar 2022 11:46AM $1.530 $1.530 $1.530 fallen by 0%
- Dividend/Distribution - API 17 Mar 2022 4:57PM $1.530 $1.530 $1.530 fallen by 0%
- WES:API S/holders vote in favour of Scheme of Arrangement 17 Mar 2022 4:38PM $1.530 $1.530 $1.530 fallen by 0%
- API Shareholders Vote in Favour of Scheme 17 Mar 2022 4:30PM $1.530 $1.530 $1.530 fallen by 0%
- Scheme Meeting - Chair's Address and Presentation 17 Mar 2022 1:50PM $1.525 $1.530 $1.530 risen by 0.33%
- Scheme Special Dividend Record Date Update 28 Feb 2022 4:50PM $1.530 $1.530 $1.530 fallen by 0%
- Ceasing to be a substantial holder 28 Feb 2022 7:47AM $1.520 $1.530 $1.530 risen by 0.66%
- Becoming a substantial holder 25 Feb 2022 7:58AM $1.530 $1.530 $1.530 fallen by 0%
- Change in substantial holding from MUFG 24 Feb 2022 3:06PM $1.525 $1.530 $1.530 risen by 0.33%
- Change in substantial holding 22 Feb 2022 6:47PM $1.525 $1.530 $1.530 risen by 0.33%
- Scheme Booklet 15 Feb 2022 2:33PM $1.525 $1.530 $1.530 risen by 0.33%
- Proxy Form - Scheme Meeting 15 Feb 2022 2:14PM $1.525 $1.530 $1.530 risen by 0.33%

1 - 25 of 477 results

Page 1 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.